Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 6 May 2024.Powered by Capital Market - Live News

Net Loss of Suven Life Sciences reported to Rs 41.76 crore in the quarter ended December 2023 as against net loss of Rs 51.12 crore during the previous quarter ended December 2022. Sales declined 18.33% to Rs 2.45 crore in the quarter ended December 2023 as against Rs 3.00 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales2.453.00 -18 OPM %-1885.71-1719.33 - PBDT-40.16-49.44 19 PBT-41.76-51.12 18 NP-41.76-51.12 18 Powered by Capital Market - Live News

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 30 January 2024.Powered by Capital Market - Live News

Net Loss of Suven Life Sciences reported to Rs 12.68 crore in the quarter ended September 2023 as against net loss of Rs 23.18 crore during the previous quarter ended September 2022. Sales declined 30.30% to Rs 3.06 crore in the quarter ended September 2023 as against Rs 4.39 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales3.064.39 -30 OPM %-768.30-494.31 - PBDT-18.41-21.56 15 PBT-20.14-23.18 13 NP-12.68-23.18 45 Powered by Capital Market - Live News

Net Loss of Suven Life Sciences reported to Rs 24.09 crore in the quarter ended June 2023 as against net loss of Rs 16.33 crore during the previous quarter ended June 2022. Sales rose 7.34% to Rs 3.80 crore in the quarter ended June 2023 as against Rs 3.54 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales3.803.54 7 OPM %-737.11-595.48 - PBDT-22.43-20.75 -8 PBT-24.09-22.33 -8 NP-24.09-16.33 -48 Powered by Capital Market - Live News